<DOC>
	<DOC>NCT02113540</DOC>
	<brief_summary>As the effect of statin use before the angiography to prevent contrast induced nephropathy (CIN) is not well-known, the aim of the current study is to assess the effect of atorvastatin on prevention of CIN in patients undergoing coronary angiography.</brief_summary>
	<brief_title>Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>having chronic stable angina who were referred for coronary angiography nonpregnant female subjects no history of diabetes mellitus no history of renal failure no history of single kidney no history of cardiogenic shock no history of unstable angina no history of myocardial infarction no history of hypersensitivity to statins no history of previous intravascular contrast injection during one month before admission glomerular filtration rate (GFR) &lt;60 cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>coronary angiography</keyword>
	<keyword>chronic stable angina</keyword>
	<keyword>CIN</keyword>
</DOC>